Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1984-03-27
1986-09-02
Roberts, Elbert L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
2603974, C07J 100, A61K 3156
Patent
active
046096507
ABSTRACT:
A novel steroid compound of the formula ##STR1## wherein A is a lower alkylene group; ##STR2## is an acyl group; and is a single bond or a double bond, and methods of producing the compound (I) as follows: ##STR3## and a pharmaceutical composition containing the compound (I). The compound (I) exhibits excellent antiandrogenic activity on oral administration and can be used for the treatment of prostatic hypertrophy.
REFERENCES:
patent: 3856829 (1974-12-01), Hiraga et al.
patent: 4119626 (1978-10-01), Schulze et al.
Nishida Yoko
Yashiki Takatsuka
Yoshimura Yoshinobu
Roberts Elbert L.
Takeda Chemical Industries Ltd.
LandOfFree
Double ester of 16.beta.-ethylestran-17.beta.-ol derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Double ester of 16.beta.-ethylestran-17.beta.-ol derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Double ester of 16.beta.-ethylestran-17.beta.-ol derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1097728